MeSH tree: C01.920.813.400
A phase 1 clinical trial testing the safety of a leishmaniasis vaccine is set to begin in the coming months—the first vaccine created to protect against the disfiguring skin disease common in tropical regions of the world ...
Jun 6, 2026
0
11
Nearly one million people worldwide are plagued annually by cutaneous leishmaniasis, a devastating skin infection caused by the Leishmania parasite. Predominantly affecting vulnerable populations in tropical and subtropical ...
Apr 7, 2025
0
13
Researchers in Brazil who analyzed samples from a 46-year-old patient in the Northeast state of Maranhão found an amphotericin B-resistant strain of the parasite Leishmania amazonensis circulating for the first time in the ...
Aug 15, 2024
0
55
For the first time, scientists have begun to figure out why the disfiguring skin lesions caused by cutaneous leishmaniasis don't hurt.
Nov 30, 2023
0
77
The parasitic disease leishmaniasis is found primarily in Central and South America, the Mediterranean region, the Middle East, and Central Asia and is transmitted to humans by a sand fly. An estimated 1.5 million new cases ...
Oct 24, 2023
0
59
The first case of concomitant visceral leishmaniasis and non-ulcerated cutaneous leishmaniasis in the same patient has been reported recently by researchers at the Federal University of São Carlos (UFSCar) in São Paulo state, ...
Aug 8, 2023
0
54
